These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22005478)

  • 1. Quantitative computed tomography analysis of emphysema and lung cancer risk.
    Smith BM
    J Thorac Oncol; 2011 Nov; 6(11):1965; author reply 1965-6. PubMed ID: 22005478
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study.
    Wilson DO; Leader JK; Fuhrman CR; Reilly JJ; Sciurba FC; Weissfeld JL
    J Thorac Oncol; 2011 Jul; 6(7):1200-5. PubMed ID: 21610523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening feasibility in Australia.
    Marshall HM; Bowman RV; Ayres J; Crossin J; Lau M; Slaughter RE; Redmond S; Passmore L; McCaul E; Courtney D; Leong SC; Windsor M; Zimmerman PV; Yang IA; Fong KM
    Eur Respir J; 2015 Jun; 45(6):1734-7. PubMed ID: 25837038
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of lung cancer screening.
    Ahmad U; Detterbeck FC
    Semin Thorac Cardiovasc Surg; 2012; 24(1):27-36. PubMed ID: 22643659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer histologies associated with emphysema on computed tomography.
    Smith BM; Schwartzman K; Kovacina B; Taylor J; Kasymjanova G; Brandao G; Agulnik JS
    Lung Cancer; 2012 Apr; 76(1):61-6. PubMed ID: 21945657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of computed tomography densitometry and pathological grading of emphysema with the variation of respiratory function after lobectomy for lung cancer.
    Carretta A; Ciriaco P; Melloni G; Ballarin A; Bandiera A; Sestini S; Giovanardi M; Zannini P
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):914-7; discussion 917-8. PubMed ID: 20308264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of combined PET/contrast-enhanced high-resolution CT fusion imaging for lung cancer.
    Lacout A; Marcy PY; Thariat J
    AJR Am J Roentgenol; 2012 Jan; 198(1):W99; author reply W100. PubMed ID: 22194526
    [No Abstract]   [Full Text] [Related]  

  • 8. Earlier Diagnosis Not Self-Evidently Beneficial: Natural History of Subcentimeter Lung Cancers.
    Reich JM; Kim JS
    AJR Am J Roentgenol; 2019 Oct; 213(4):817-818. PubMed ID: 31120792
    [No Abstract]   [Full Text] [Related]  

  • 9. Staging of non-small cell lung cancer using integrated PET/CT.
    Kligerman S; Digumarthy S
    AJR Am J Roentgenol; 2009 Nov; 193(5):1203-11. PubMed ID: 19843732
    [No Abstract]   [Full Text] [Related]  

  • 10. Focal hepatic enhancement on computed tomography in a patient with non-small cell lung carcinoma.
    Wallach AP; Hazelton TR
    Cancer Control; 2001; 8(2):184; discussion 189. PubMed ID: 11326174
    [No Abstract]   [Full Text] [Related]  

  • 11. Thin-section CT as an optimal diagnostic tool in the evaluation of dry pleural dissemination in non-small cell lung cancer.
    Jiang T; Zheng X; Liu S
    Radiology; 2012 Jan; 262(1):368-9; author reply 369. PubMed ID: 22190662
    [No Abstract]   [Full Text] [Related]  

  • 12. Counterpoint: Despite staging inaccuracies, patients with non-small cell lung cancer are best served by having integrated positron emission tomography/computed tomography before therapy.
    Cerfolio RJ
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):20-2. PubMed ID: 19154894
    [No Abstract]   [Full Text] [Related]  

  • 13. An original case of lip metastasis, from non small cell lung cancer.
    Gupta M; Choudhary PS; Avinash Rao S; Mehta A
    Hell J Nucl Med; 2010; 13(2):173-4. PubMed ID: 20808995
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging in lung cancer.
    Barrington SF; O'Doherty MJ
    Nucl Med Commun; 1996 Mar; 17(3):173-5. PubMed ID: 8692482
    [No Abstract]   [Full Text] [Related]  

  • 15. CT measurement of blood flow through lung cancers.
    Milne EN
    Radiology; 2011 May; 259(2):613; author reply 613-4. PubMed ID: 21502398
    [No Abstract]   [Full Text] [Related]  

  • 16. The staging system for non-small cell lung cancer: time for an overhaul?
    Barnes DJ
    Chest; 2007 Apr; 131(4):948-9. PubMed ID: 17426192
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung cancer-elapsed time from suspicious radiograph to treatment: how fast is fast enough?
    Torrington KG
    J Thorac Oncol; 2008 Sep; 3(9):947-8. PubMed ID: 18758293
    [No Abstract]   [Full Text] [Related]  

  • 18. Relearning the lessons of the past: are we making progress?
    Detterbeck FC
    Ann Thorac Surg; 2005 Nov; 80(5):1979-80; author reply 1980-1. PubMed ID: 16242512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical target volume in radiotherapy of non-small cell lung carcinoma].
    Li WL; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):513-6. PubMed ID: 15555277
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic staging of lung cancer.
    Berlangieri SU; Scott AM
    N Engl J Med; 2000 Jul; 343(4):290-2. PubMed ID: 10911013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.